Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Stock Short Interest Rises 157.8%

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) saw a large increase in short interest in September. As of September 30th, there was short interest totaling 526 shares, an increase of 157.8% from the September 15th total of 204 shares. Based on an average trading volume of 94 shares, the days-to-cover ratio is currently 5.6 days. Approximately 0.0% of the shares of the stock are short sold.

Orion OYJ Price Performance

ORINY stock remained flat at $46.65 during midday trading on Tuesday. The company had a trading volume of 275 shares, compared to its average volume of 1,575. The company has a market cap of $13.17 billion, a PE ratio of 19.20 and a beta of 0.07. Orion OYJ has a twelve month low of $30.89 and a twelve month high of $48.79. The company has a quick ratio of 1.48, a current ratio of 2.64 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average of $45.42 and a two-hundred day moving average of $41.14.

Orion OYJ (OTCMKTS:ORINY) last posted its earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%. The firm had revenue of $606.38 million during the quarter.

Orion OYJ Company Profile

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.

The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.